NSAIDs and Triptans – a (not) New Treatment Option for Migraine

Every day, around 7% of population will experience headache caused by migraine. Migraine is one of the leading causes of years lived with disability, and it also causes significant negative economic impact, as most as the affected population is of working age. Pathogenesis of migraine includes neur...

Full description

Saved in:
Bibliographic Details
Main Authors: B. Kakta, Rasa Mameniškienė
Format: Article
Language:English
Published: Vilnius University Press 2023-12-01
Series:Neurologijos seminarai
Subjects:
Online Access:https://www.journals.vu.lt/neurologijos_seminarai/article/view/37597
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832593120234045440
author B. Kakta
Rasa Mameniškienė
author_facet B. Kakta
Rasa Mameniškienė
author_sort B. Kakta
collection DOAJ
description Every day, around 7% of population will experience headache caused by migraine. Migraine is one of the leading causes of years lived with disability, and it also causes significant negative economic impact, as most as the affected population is of working age. Pathogenesis of migraine includes neurogenic inflammation, which, in turn, causes peripheral sensitization of trigeminal nerve mechanoreceptors. As peripheral sensitization lingers on, central sensitization of the spinal trigeminal nucleus occurs. Non-steroidal anti-inflammatory drugs and triptans are first line treatment of a migraine attack. Nevertheless, when used in combination, these medications deliver a synergistic action. In this article, we review a combination of sumatriptan and naproxen sodium for the treatment of migraine headache as an underused treatment option in Lithuania.
format Article
id doaj-art-b07a23ec0d944a8f8534abf9674919b1
institution Kabale University
issn 1392-3064
2424-5917
language English
publishDate 2023-12-01
publisher Vilnius University Press
record_format Article
series Neurologijos seminarai
spelling doaj-art-b07a23ec0d944a8f8534abf9674919b12025-01-20T18:22:00ZengVilnius University PressNeurologijos seminarai1392-30642424-59172023-12-01274(98)10.15388/NS.2023.27.98.7NSAIDs and Triptans – a (not) New Treatment Option for MigraineB. Kakta0Rasa Mameniškienė1Vilnius University, LithuaniaVilnius University, Lithuania Every day, around 7% of population will experience headache caused by migraine. Migraine is one of the leading causes of years lived with disability, and it also causes significant negative economic impact, as most as the affected population is of working age. Pathogenesis of migraine includes neurogenic inflammation, which, in turn, causes peripheral sensitization of trigeminal nerve mechanoreceptors. As peripheral sensitization lingers on, central sensitization of the spinal trigeminal nucleus occurs. Non-steroidal anti-inflammatory drugs and triptans are first line treatment of a migraine attack. Nevertheless, when used in combination, these medications deliver a synergistic action. In this article, we review a combination of sumatriptan and naproxen sodium for the treatment of migraine headache as an underused treatment option in Lithuania. https://www.journals.vu.lt/neurologijos_seminarai/article/view/37597migraineNSAIDstriptanssumatriptan and naproxen sodium
spellingShingle B. Kakta
Rasa Mameniškienė
NSAIDs and Triptans – a (not) New Treatment Option for Migraine
Neurologijos seminarai
migraine
NSAIDs
triptans
sumatriptan and naproxen sodium
title NSAIDs and Triptans – a (not) New Treatment Option for Migraine
title_full NSAIDs and Triptans – a (not) New Treatment Option for Migraine
title_fullStr NSAIDs and Triptans – a (not) New Treatment Option for Migraine
title_full_unstemmed NSAIDs and Triptans – a (not) New Treatment Option for Migraine
title_short NSAIDs and Triptans – a (not) New Treatment Option for Migraine
title_sort nsaids and triptans a not new treatment option for migraine
topic migraine
NSAIDs
triptans
sumatriptan and naproxen sodium
url https://www.journals.vu.lt/neurologijos_seminarai/article/view/37597
work_keys_str_mv AT bkakta nsaidsandtriptansanotnewtreatmentoptionformigraine
AT rasamameniskiene nsaidsandtriptansanotnewtreatmentoptionformigraine